Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

PIC/S GMP Guide: Structure and Annex Alignment

Posted on June 14, 2025 By digi

PIC/S GMP Guide: Structure and Annex Alignment

Understanding the PIC/S GMP Guide Structure and Annex Alignment

The Pharmaceutical Inspection Co-operation Scheme (PIC/S) has played a pivotal role in harmonizing Good Manufacturing Practice (GMP) standards globally. Its core document—the PIC/S GMP Guide—provides a standardized framework for inspection readiness and regulatory alignment. Modeled closely after the EU GMP (EudraLex Volume 4), the PIC/S guide maintains a structured format that includes core chapters and annexes. This article presents an expert walkthrough of the PIC/S GMP Guide structure and annex alignment, highlighting its value in fostering global compliance and audit preparedness.

Introduction to the PIC/S GMP Guide

  • The PIC/S GMP Guide mirrors the structure of the EU GMP Guide (EudraLex Volume 4)
  • Serves as a harmonized reference for over 50 regulatory authorities worldwide
  • Regularly updated to reflect current best practices, scientific advancements, and global consensus
  • Supports mutual recognition and harmonized inspections across member countries

Structure of the PIC/S GMP Guide

The guide is composed of three main parts followed by detailed annexes:

  • Part I: GMP for medicinal products
  • Part II: GMP for active pharmaceutical ingredients (aligned with ICH Q7)
  • Part III: GMP-related documents (guidance, templates, Q&As)
Also Read:  Common GMP Violations Noted in FDA 483s

Part I – GMP for Medicinal Products

Part I is divided into nine chapters covering the essential elements of a pharmaceutical quality system:

  1. Pharmaceutical Quality System
  2. Personnel
  3. Premises and Equipment
  4. Documentation
  5. Production
  6. Quality Control
  7. Outsourced Activities
  8. Complaints and Product Recall
  9. Self-Inspection

These chapters serve as the baseline for inspection protocols and align with pharmaceutical SOPs globally.

Part II – GMP for Active Pharmaceutical Ingredients (APIs)

  • Directly aligned with ICH Q7 guidance
  • Covers API lifecycle from raw materials to packaging
  • Applies to chemical synthesis, fermentation, biotech, and other API manufacturing processes
  • Focus areas include:
    • Material management
    • Contamination control
    • Validation
    • Process deviations

Part III – Related GMP Documents

  • Includes GMP templates, inspection guidance, and interpretation documents
  • Annexes specific to emerging technologies and risk-based quality systems
  • Provides Q&A documents for clarification on implementation challenges

Annexes in the PIC/S GMP Guide

The annexes supplement core chapters with product- or process-specific guidance. The most commonly used annexes include:

  • Annex 1: Manufacture of Sterile Medicinal Products (revamped in 2023)
  • Annex 2: Biological Medicinal Substances and Products
  • Annex 3: Radiopharmaceuticals
  • Annex 6: Medicinal Gases
  • Annex 11: Computerised Systems
  • Annex 15: Qualification and Validation
  • Annex 16: Certification by a Qualified Person (QP) and Batch Release
  • Annex 17: Real Time Release Testing and Parametric Release
  • Annex 19: Reference and Retention Samples
Also Read:  US FDA’s Approach to Biologics and ATMP Inspections

Alignment with EU GMP Annexes

  • PIC/S annexes are harmonized with the latest updates from EudraLex Volume 4
  • EU and PIC/S often issue parallel revisions to Annex 1, 11, and 15
  • This allows global manufacturers to follow a single integrated GMP model
  • Also facilitates inspection readiness for both EU NCAs and PIC/S members

Key Highlights of Select Annexes

Annex 1 – Sterile Medicinal Products

  • Focuses on contamination control strategies (CCS)
  • Introduces quality risk management (QRM) concepts
  • Defines requirements for cleanroom classification and aseptic validation

Annex 11 – Computerised Systems

  • Applies to all GMP-regulated IT systems
  • Emphasizes data integrity, audit trails, and system validation
  • Often used alongside GAMP 5 principles for computerized system lifecycle management

Annex 15 – Qualification and Validation

  • Covers lifecycle validation including DQ, IQ, OQ, PQ stages
  • Applies to process, cleaning, analytical methods, and utilities
  • Provides a roadmap for validation master planning
Also Read:  How PIC/S Enhances GMP Harmonization Across Borders

How to Use the PIC/S Guide for Compliance

  1. Integrate relevant chapters and annexes into internal QMS documentation
  2. Map your operations to the applicable parts (e.g., Part I for finished dosage, Part II for API)
  3. Use annexes as checkpoints during self-inspections and external audits
  4. Train staff using annex-based modules (e.g., Annex 1 for aseptic operators)
  5. Prepare for inspections by cross-referencing annex expectations against your stability protocols and batch records

Advantages of PIC/S Guide Alignment

  • Ensures inspection preparedness across multiple jurisdictions
  • Enables smoother product registration with international regulators
  • Supports mutual recognition and global GMP reliance frameworks
  • Provides a harmonized vocabulary and structure for regulatory communication

Conclusion

The PIC/S GMP Guide offers a globally accepted, structured, and harmonized framework for GMP compliance. Its alignment with EU GMP and integration of ICH and WHO principles ensures manufacturers can confidently prepare for inspections across borders. By understanding its structure and annex alignment, pharmaceutical professionals can strengthen their quality systems, enhance global trust, and ensure patient safety in every market they serve.

International GMP Inspection Standards and Harmonization, PIC/S Role in Harmonized Inspections Tags:annex 1 PIC/S, annex 11 computerized systems, annex 15 validation, EU GMP vs PIC/S, GMP annex interpretation, GMP annexes PIC/S, GMP cross-references, GMP documentation structure, GMP harmonization tools, GMP quality system alignment, pharmaceutical GMP harmonization, PIC/S annex alignment, PIC/S GMP guide structure, PIC/S guideline chapters, PIC/S regulatory guide

Post navigation

Previous Post: How to Interpret a PIC/S GMP Certificate
Next Post: Ensure QA Oversight in Destruction of GMP Rejected Products

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog
Widget Image
  • Ensure QA Oversight in Destruction of GMP Rejected Products

    Ensure QA Oversight in Destruction… Read more

International GMP Inspection Standards and Harmonization

  • Global GMP Inspection Frameworks
  • WHO Prequalification and Inspection Systems
  • US FDA GMP Inspection Programs
  • EMA and EU GMP Inspection Practices
  • PIC/S Role in Harmonized Inspections
  • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)

International GMP Inspection Standards and Harmonization, PIC/S Role in Harmonized Inspections

  • PIC/S GMP Guide: Structure and Annex Alignment
  • How to Interpret a PIC/S GMP Certificate
  • Mutual Recognition Through PIC/S Participation
  • Comparison of PIC/S and WHO GMP Inspection Models
  • How PIC/S Enhances GMP Harmonization Across Borders
  • Objectives and Scope of PIC/S in Global GMP
  • PIC/S Membership: Countries and Agencies Involved
  • Introduction to the Pharmaceutical Inspection Co-operation Scheme (PIC/S)
  • EMA’s Harmonization with WHO PQP and PIC/S
  • EMA GMP Inspection Templates and Tools

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme